Nonalcoholic Steatohepatitis (NASH) Latest Advances
Find the Latest Research About Nonalcoholic Steatohepatitis (NASH)
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5303 publications
Expression of Concern: Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Journal: Clinical science (London, England : 1979)
Published: October 14, 2026
Saikosaponin D Ameliorates Non-alcoholic Steatohepatitis by Inhibiting STING-Mediated Macrophage M1 Polarization in Mice.
Journal: Biological & pharmaceutical bulletin
Published: September 23, 2026
Hepatoprotection of Jianpi Qingre Lishi prescription on non-alcoholic steatohepatitis miRNA-27/peroxisome proliferator-activated receptor gamma axis.
Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
Published: June 28, 2026
14-Deoxy-11,12-didehydroandrographolide Attenuates Lipotoxicity and Non-Alcoholic Steatohepatitis Through Restoration of Autophagy and Reduction in Oxidative Stress.
Journal: International journal of molecular sciences
Published: June 19, 2026
Smilax glabra flavonoids ameliorate non-alcoholic steatohepatitis by regulating PKM2-dependent glycolysis and suppressing AIM2 inflammasome activation.
Journal: Frontiers in immunology
Published: June 11, 2026
Shared Tissue-Level Molecular Signatures and Immunometabolic Associations in Nonalcoholic Steatohepatitis and Chronic Kidney Disease: Potential Endothelial Relevance.
Journal: Journal of inflammation research
Published: May 27, 2026
Analysis of pathogenesis-related factors of Streptococcus mutans from the oral cavity of patients with nonalcoholic steatohepatitis.
Journal: Frontiers in immunology
Published: May 12, 2026
Correction: Empagliflozin attenuates dexamethasone-induced non-alcoholic steatohepatitis by regulation of ferroptosis, inflammation and autophagy.
Journal: Frontiers in pharmacology
Published: May 07, 2026
Corrigendum to "CISD2-mediated mitochondrial dysfunction and iron redistribution contributes to ferroptosis in arsenic-induced nonalcoholic steatohepatitis" [Ecotoxicol. Environ. Saf. 289:117694/EES-23-4255].
Journal: Ecotoxicology and environmental safety
Published: April 15, 2026
Comment on "Unveiling Resmetirom: A Systematic Review and Meta-Analysis on Its Impact on Liver Function and Safety in Non-Alcoholic Steatohepatitis Treatment".
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: April 06, 2026
Last Updated: 11/08/2026